Table 3 Dose Escalation Regression Estimates – Inflixim ab and Etanercept Dependent Variables (Increase in dose for Inflixim ab or Etanercept 1 = yes, 0 = no)
Parameter | Level | Estimate | Odds-Ratio | Transformed Odds Ratio | Conditional Probability | p-value |
|---|---|---|---|---|---|---|
Intercept | -0.3129 | 0.73 | n.a. | n.a. | 0.1702 | |
HMO | Yes | -0.2246 | 0.80 | 1.00 | 0.37 | 0.0826 |
No | 0.0000 | 1.00 | 1.25 | 0.42 | ||
Treatment | Inflixim ab | 0.0000 | 1.00 | 6.38 | 0.42 | |
Etanercept | -1.8529 | 0.16 | 1.00 | 0.10 | <.0001 | |
Region | West | 0.0000 | 1.00 | 1.00 | 0.42 | |
Northeast | 0.6505 | 1.92 | 1.92 | 0.58 | 0.0215 | |
Midwest | 0.6382 | 1.89 | 1.89 | 0.58 | 0.0063 | |
South | 0.6252 | 1.87 | 1.87 | 0.58 | 0.0102 | |
Pre-Period Non RA Related Costs ('000s) | Yes | 0.0350 | 1.04 | 1.04 | 0.43 | 0.0185 |
No | 1.00 | 1.00 | 0.42 | |||
Crohn's Disease | Yes | -0.7328 | 0.48 | 1.00 | 0.26 | 0.0477 |
No | 0.0000 | 1.00 | 2.08 | 0.42 | ||
Cox-IIs | Yes | 0.3064 | 1.36 | 1.36 | 0.50 | 0.0175 |
No | 0.0000 | 1.00 | 1.00 | 0.42 |